Bloch Michael J, Basile Jan
Division of General Internal Medicine/ Division of Cardiology, University of Nevada School of Medicine, Reno, NV 89502, USA.
J Clin Hypertens (Greenwich). 2007 May;9(5):381-9. doi: 10.1111/j.1524-6175.2007.06573.x.
Renovascular disease is a common but complex disorder, the most common causes of which are fibromuscular dysplasia and atherosclerosis. Clinically, it can present as asymptomatic renal artery stenosis, renovascular hypertension, or ischemic nephropathy. Assessing the clinical index of suspicion remains essential in determining an appropriate diagnostic strategy. For diagnosis in patients with suspected fibromuscular disease, it may be reasonable to proceed directly to renal angiography; however, for most patients with suspected atherosclerotic disease, there are a number of noninvasive tests available that can aid in decision making. The choice of the most appropriate initial test should be based on patient characteristics, clinical presentation, and local expertise. Treatment options include medical, surgical, or percutaneous approaches. Generally, in patients with fibromuscular disease, percutaneous intervention provides durable improvement or cure of hypertension. In patients with atherosclerotic disease, the data are less consistent, and there does appear to be a group of patients who will respond well to medical management alone. As technology advances, the diagnostic and treatment paradigms will continue to evolve.
肾血管疾病是一种常见但复杂的病症,其最常见的病因是纤维肌发育不良和动脉粥样硬化。临床上,它可表现为无症状性肾动脉狭窄、肾血管性高血压或缺血性肾病。评估可疑的临床指标对于确定合适的诊断策略仍然至关重要。对于疑似纤维肌疾病患者的诊断,直接进行肾血管造影可能是合理的;然而,对于大多数疑似动脉粥样硬化疾病的患者,有许多非侵入性检查可帮助做出决策。最合适的初始检查的选择应基于患者特征、临床表现和当地专业知识。治疗选择包括药物、手术或经皮治疗方法。一般来说,对于纤维肌疾病患者,经皮干预可持久改善或治愈高血压。对于动脉粥样硬化疾病患者,数据不太一致,似乎有一组患者仅通过药物治疗就会有良好反应。随着技术的进步,诊断和治疗模式将继续发展。